Figure 3.
Figure 3. Causes of death among patients who developed subsequent solid cancer after HCT. (A) Autologous HCT. Skin and prostate cancers are excluded because no death occurred with these cancers. (B) Allogeneic HCT.

Causes of death among patients who developed subsequent solid cancer after HCT. (A) Autologous HCT. Skin and prostate cancers are excluded because no death occurred with these cancers. (B) Allogeneic HCT.

Close Modal

or Create an Account

Close Modal
Close Modal